홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ANIK
#2995
Anika Therapeutics Inc
14.360
0
+14.42%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+14.42%
월간 변동
+55.50%
6달 변화
+41.62%
년간 변동율
+41.62%
이전 종가
12.550
0
Open
14.360
0
Bid
Ask
Low
14.360
0
High
14.360
0
양
44
마켓
주식
헬스케어
ANIK
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
14.33 M
14.47 M
14.63 M
14.85 M
14.18 M
—
Valuation ratios
Enterprise value
552.74 M
423.97 M
345.05 M
263.63 M
177.71 M
516.83 M
Price to earnings ratio
-26.78
127.96
-28.9
-4.02
-4.3
-14.88
Price to sales ratio
4.93
3.55
2.75
1.99
2.02
6.08
Price to cash flow ratio
49.27
62.44
97.36
185.74
44.85
137.02
Price to book ratio
2.36
1.83
1.5
1.56
1.57
2.37
Enterprise value to EBITDA ratio
-9.28
-41.24
-28.67
-3.36
-29.24
-41.01
Profitability ratios
Return on assets %
0.07
0.01
0.04
0.31
0.28
0.17
Return on equity %
0.09
0.01
0.05
0.39
0.37
0.22
Return on invested capital %
50.18
1.3
28.3
200.62
-20.05
49.65
Gross margin %
52.91
56.12
59.89
61.85
63.38
218.99
Operating margin %
21.71
1.77
12.42
52.58
4.25
45.11
EBITDA margin %
-45.63
-6.96
-7.7
-47.08
-5.07
-51.21
Net margin %
18.38
2.8
9.51
49.6
47.02
112.51
Liquidity ratios
Quick ratio
3.56
4.45
4.65
3.76
3.85
17.98
Current ratio
4.81
5.66
6.07
5.26
4.88
22.1
Inventory turnover
1.8
1.58
1.65
1.48
1.25
2.39
Asset turnover
0.37
0.41
0.45
0.54
0.51
0.57
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.92
0.57
0.3
0.12
0.37
0.56
EBIT per share
-5.15
-1.69
-1.83
-6.32
-0.8
-1.42
EBITDA per share
-4.19
-0.7
-0.83
-5.35
-0.41
-0.99
Total debt per share
—
—
—
—
—
—
Cash per share
6.91
6.45
8.31
7.43
5.38
21.53
Net current asset value per share
12.47
11.52
11.64
11.14
7.72
28.78
Tangible book value per share
12.15
13.46
13.98
13.65
9.81
38.52
Working capital per share
9.88
9.48
9.73
9.02
6.14
23.51
Book value per share
19.15
19.62
19.61
14.48
10.46
41.19
뉴스
Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates
Anika 2025년 4분기 실적 발표: 상업 채널 성장, OEM 부진 상쇄
Anika Q4 2025 slides: commercial surge offsets OEM decline
Anika Therap Q4 실적, 수익 예상치를 넘어
Anika earnings beat by $0.45, revenue topped estimates
Lumicell appoints Cheryl Blanchard to board of directors
애니카 테라퓨틱스, 스티븐 그리핀을 차기 CEO로 임명
Anika Therapeutics names Stephen Griffin as new CEO
애니카 2025년 3분기 실적: 상업 성장, OEM 감소 상쇄
Anika Q3 2025 slides: Commercial growth offsets OEM decline
Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates
Anika earnings beat by $0.22, revenue was in line with estimates